Figure 2.
T2-weighted magnetic resonance imaging of no. 5 patient before bevacizumab treatment (left) and 25 weeks later (right).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.